Landmark Study Published in American Journal of Obstetrics & Gynecology Validates New Blood Test as Objective, Predictive Tool for Preterm Birth Risk
10. März 2016 07:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, March 10, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that clinical validation data from the 5,501 patient Proteomic Assessment of...
Positive Clinical Validation Data for PreTRM® Test Presented at the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy Meeting
04. Februar 2016 15:15 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that results from the 5,501-patient Proteomic Assessment of Preterm Risk...
Sera Prognostics Announces Clinical Study Data Selected for Presentation at the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy Meeting
07. Januar 2016 17:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that findings from the 5,501 patient Proteomic Assessment of Preterm Risk...
Sera Prognostics to Present at 34th Annual J.P. Morgan Healthcare Conference
21. Dezember 2015 12:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, todayannounced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics to Present at 27th Annual Piper Jaffray Healthcare Conference
24. November 2015 12:24 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics Announces Early Limited Commercial Access of Its PreTRM™ Test
19. Oktober 2015 10:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Oct. 19, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced a program for early limited commercial access to PreTRM™, a proteomic...
Sera Prognostics Appoints Investor Arnold L. Oronsky, Ph.D., to Board of Directors
24. Februar 2015 09:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 24, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that Arnold L. Oronsky, Ph.D., General Partner at InterWest Partners, LLC, was...
Sera Prognostics Increases Series B Financing to $25M With New Investor
04. Februar 2015 07:30 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 4, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that the Bill & Melinda Gates Foundation has agreed to join the Company's...
Sera Prognostics Closes $20 Million in Series B Financing
07. Januar 2015 09:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that it has closed $20 Million in Series B financing. Leading the Series B...
Sera Prognostics to Present at 33rd Annual J.P. Morgan Healthcare Conference
23. Dezember 2014 09:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 23, 2014 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...